Canadian FHIR Baseline Profiles - Due Diligence Review - IPS – April 9th, 2-3pm EST

Attendees:

Michael Savage
Sheridan Cook
Rita Pyle
Dan Simic
Thomas Zhou
Shamil Nizamov
Randy Nonay
Ken Sinn
Joel Francis
Jason Lin
Harsh Sharma
Fariba Behzadi
Anne Belford
Joan Harper

• The group continued the Due Diligence Review comparing CA Baseline with IPS FHIR iGuide
• General suggestion to move binding strengths from ‘example’ to ‘preferred’ where the CA Baseline is in-sync with the terminology / value sets defined in the iGuides
• Request is for reviewers to flag these suggested changes in the issue log for each CA Baseline Profile

MedicationStatement

• .effective.ext (data absent reason)
o Mixed thoughts on whether or not to socialize this extension in the Baseline; can also include this in implementation guidance, without defining in the structure definition as an extension

• .dateAsserted
o Flag for relaxing Must Support flag on this element in CA Baseline

• .derivedFrom
o Same as above

Condition

• .clinicalStatus & .verificationStatus
o Need to review our decisions on these modifier flags based on our previous DDRs with condition profile

• .code.coding
o Flagged for further review based on our approach to slices in other .coding elements in other DDRs and other Baseline Profiles

Next time: Will continue with IPS DDR, looking at AllergyIntolerance

Hi all!

For our upcoming meeting on Friday April 9th, we will be continuing our Due Diligence Review of the International Patient Summary, specifically looking at the following profiles:

MedicationStatement
AllergyIntolerance
Condition

Thank you!